Literature DB >> 14969817

Overexpression of cyclooxygenase-2 is associated with radioresistance in oral squamous cell carcinoma.

Nagaaki Terakado1, Satoru Shintani, Junya Yano, Li Chunnan, Mariko Mihara, Koh-ichi Nakashiro, Hiroyuki Hamakawa.   

Abstract

Cyclooxygenase-2 (COX-2), an inducible isoform of cyclooxygenase, is overexpressed in many types of malignant tumors, which in turn may stimulate tumor growth and protect against damage by irradiation or cytotoxic agents. The purpose of this study is to investigate the relationship between the radiation sensitivity and elevated level of COX-2. Radiation sensitivity of the eight oral SCC cell lines differed greatly in their response to radiation. Further, the level of the COX-2 expression correlated inversely with increased tumor radiation sensitivity. The similar significant association between the response to preoperative radiation therapy and COX-2 overexpression was observed in the oral SCC patients. In addition, treatment with a COX-2 selective inhibitor enhanced the radioresponse of HSC-2 cell, which constitutively expressed COX-2. These results suggested that COX-2 expression level correlates to radiation tolerance and the COX-2 selective inhibitor may be a potent enhancer for tumor radioresponse in oral SCC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14969817     DOI: 10.1016/j.oraloncology.2003.09.005

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  13 in total

1.  Celecoxib enhances the radiosensitivity of HCT116 cells in a COX-2 independent manner by up-regulating BCCIP.

Authors:  Xiao-Ting Xu; Wen-Tao Hu; Ju-Ying Zhou; Yu Tu
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

2.  Inhibition of invasion-associated thromboxane synthase sensitizes experimental gliomas to gamma-radiation.

Authors:  Anne Katrin Schauff; Ella L Kim; Jan Leppert; Roger Nadrowitz; Robin Wuestenberg; Mark Alexander Brockmann; Alf Giese
Journal:  J Neurooncol       Date:  2008-09-30       Impact factor: 4.130

3.  Effects of propranolol in combination with radiation on apoptosis and survival of gastric cancer cells in vitro.

Authors:  Xinhua Liao; Xiangming Che; Wei Zhao; Danjie Zhang; Houlong Long; Prakash Chaudhary; Haijun Li
Journal:  Radiat Oncol       Date:  2010-10-26       Impact factor: 3.481

4.  COX-2 promotes breast cancer cell radioresistance via p38/MAPK-mediated cellular anti-apoptosis and invasiveness.

Authors:  Fengjuan Lin; Jianmin Luo; Wen Gao; Jiong Wu; Zhimin Shao; Ziliang Wang; Jiao Meng; Zhouluo Ou; Gong Yang
Journal:  Tumour Biol       Date:  2013-06-15

5.  The role of COX-2 in rectal cancer treated with preoperative radiotherapy.

Authors:  Hanifa Bouzourene; Pu Yan; Dominique Sandmeier; Abderrahim Zouhair; Maurice Matter; Henri Vuilleumier; Philippe Coucke
Journal:  Virchows Arch       Date:  2008-05       Impact factor: 4.064

6.  Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers.

Authors:  Reza Ehsanian; Carter Van Waes; Stephan M Feller
Journal:  Cell Commun Signal       Date:  2011-05-15       Impact factor: 5.712

7.  Overexpression of COX-2 in oral squamous cell carcinoma patients undergoing chemoradiotherapy.

Authors:  Shadab Mohammad; Hari Ram; Prem Narayan Gupta; Nuzhat Husain; M L B Bhatt
Journal:  Natl J Maxillofac Surg       Date:  2011-01

8.  Raman spectroscopic study of radioresistant oral cancer sublines established by fractionated ionizing radiation.

Authors:  Mohd Yasser; Rubina Shaikh; Murali Krishna Chilakapati; Tanuja Teni
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

9.  Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer.

Authors:  James M Cleary; Harvey J Mamon; Jackie Szymonifka; Raphael Bueno; Noah Choi; Dean M Donahue; Panos M Fidias; Henning A Gaissert; Michael T Jaklitsch; Matthew H Kulke; Thomas P Lynch; Steven J Mentzer; Jeffrey A Meyerhardt; Richard S Swanson; John Wain; Charles S Fuchs; Peter C Enzinger
Journal:  BMC Cancer       Date:  2016-07-13       Impact factor: 4.430

10.  Role of matrix metalloproteinase 13 gene expression in the evaluation of radiation response in oral squamous cell carcinoma.

Authors:  Shankar Sharan Singh; Madan Lal Brahma Bhatt; Vandana Singh Kushwaha; Anshuman Singh; Rajendra Kumar; Rajeev Gupta; Devendra Parmar
Journal:  J Carcinog       Date:  2017-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.